• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2',3'-双脱氧胸苷及其2',3'-不饱和衍生物(2',3'-双脱氧胸苷烯)在体外都是人类免疫缺陷病毒复制的强效和选择性抑制剂。

Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.

作者信息

Baba M, Pauwels R, Herdewijn P, De Clercq E, Desmyter J, Vandeputte M

出版信息

Biochem Biophys Res Commun. 1987 Jan 15;142(1):128-34. doi: 10.1016/0006-291x(87)90460-8.

DOI:10.1016/0006-291x(87)90460-8
PMID:3028398
Abstract

2',3'-Dideoxythymidine (ddThd) and its 2',3'-unsaturated derivative 2',3'-dideoxythymidinene (ddeThd) are potent and selective inhibitors of human immunodeficiency virus (HIV) in vitro. When evaluated for their inhibitory effects on the cytopathogenicity of HIV in MT-4 cells, ddThd and ddeThd completely protected the cells against destruction by the virus at a concentration of 1 microM and 0.04 microM, respectively. In this aspect, ddeThd was about 5 times more potent than 2',3'-dideoxycytidine (ddCyd), one of the most potent and selective anti-HIV compounds now pursued for its therapeutic potential in the treatment of AIDS. ddThd and ddeThd also suppressed HIV antigen expression at 1 microM and 0.04 microM, respectively. Their selectivity indexes, as based on the ratio of the 50% cytotoxic dose to the 50% antiviral effective dose, were 120 (ddeThd) and greater than 625 (ddThd).

摘要

2',3'-双脱氧胸苷(ddThd)及其2',3'-不饱和衍生物2',3'-双脱氧胸苷烯(ddeThd)在体外是人类免疫缺陷病毒(HIV)的强效和选择性抑制剂。当评估它们对MT-4细胞中HIV细胞病变效应的抑制作用时,ddThd和ddeThd分别在浓度为1微摩尔和0.04微摩尔时完全保护细胞免受病毒破坏。在这方面,ddeThd的效力约为2',3'-双脱氧胞苷(ddCyd)的5倍,ddCyd是目前因其在治疗艾滋病方面的治疗潜力而被研究的最有效的选择性抗HIV化合物之一。ddThd和ddeThd也分别在1微摩尔和0.04微摩尔时抑制HIV抗原表达。基于50%细胞毒性剂量与50%抗病毒有效剂量之比的选择性指数分别为120(ddeThd)和大于625(ddThd)。

相似文献

1
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.2',3'-双脱氧胸苷及其2',3'-不饱和衍生物(2',3'-双脱氧胸苷烯)在体外都是人类免疫缺陷病毒复制的强效和选择性抑制剂。
Biochem Biophys Res Commun. 1987 Jan 15;142(1):128-34. doi: 10.1016/0006-291x(87)90460-8.
2
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.作为潜在抗HIV(HTLV-III/LAV)药物的3'-取代的2',3'-二脱氧核苷类似物。
J Med Chem. 1987 Aug;30(8):1270-8. doi: 10.1021/jm00391a003.
3
The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.2',3'-二脱氢-2',3'-二脱氧核糖核苷的抗HTLV-III(抗HIV)及细胞毒性活性:与其母体2',3'-二脱氧核糖核苷的比较
Mol Pharmacol. 1987 Jul;32(1):162-7.
4
Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.2',3'-二脱氢-2',3'-二脱氧核苷对人类免疫缺陷病毒的感染性、细胞病变效应及复制的抑制作用
Antimicrob Agents Chemother. 1987 Jun;31(6):907-10. doi: 10.1128/AAC.31.6.907.
5
Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus.在MT-4细胞上进行灵敏且快速的检测,以检测抗艾滋病病毒的抗病毒化合物。
J Virol Methods. 1987 Jun;16(3):171-85. doi: 10.1016/0166-0934(87)90002-4.
6
Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides.不同糖修饰的嘧啶和嘌呤核苷的合成及其抗HIV活性
J Med Chem. 1988 Oct;31(10):2040-8. doi: 10.1021/jm00118a033.
7
Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine.
Biochem Biophys Res Commun. 1988 Jun 16;153(2):825-31. doi: 10.1016/s0006-291x(88)81170-7.
8
Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.两种强效抗人类免疫缺陷病毒化合物2',3'-二脱氢-2',3'-二脱氧胸苷和3'-叠氮基-2',3'-二脱氧胸苷的细胞内代谢差异模式。
J Biol Chem. 1989 Apr 15;264(11):6127-33.
9
Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.2',3'-双脱氧核苷体外抑制HIV-2和SIV在辅助性T细胞中的感染性及复制
AIDS Res Hum Retroviruses. 1988 Apr;4(2):107-13. doi: 10.1089/aid.1988.4.107.
10
Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro.
Biochem Biophys Res Commun. 1987 Jun 30;145(3):1080-6. doi: 10.1016/0006-291x(87)91547-6.

引用本文的文献

1
Sixty Years at the Rega Institute.鲁汶大学雷加研究所的六十年
Viruses. 2025 Feb 5;17(2):222. doi: 10.3390/v17020222.
2
Selected Milestones in Antiviral Drug Development.抗病毒药物研发的重要里程碑
Viruses. 2024 Jan 23;16(2):169. doi: 10.3390/v16020169.
3
Hydrogen Bonding (Base Pairing) in Antiviral Activity.氢键(碱基配对)在抗病毒活性中的作用。
Viruses. 2023 May 10;15(5):1145. doi: 10.3390/v15051145.
4
Reflections on the Rega Institute for Medical Research, at the fiftieth anniversary of the Rega Stichting vzw (Rega Instituut vzw, Rega Foundation).雷吉奥医学研究协会五十周年纪念文集(雷吉奥协会 vzw,雷吉奥基金会)。
Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221129979. doi: 10.1177/20402066221129979.
5
Advances in Therapeutic -Nucleosides and -Nucleic Acids with Unusual Handedness.手性治疗性核苷和核酸的研究进展。
Genes (Basel). 2021 Dec 24;13(1):46. doi: 10.3390/genes13010046.
6
Tribute to John C. Martin at the Twentieth Anniversary of the Breakthrough of Tenofovir in the Treatment of HIV Infections.纪念在抗 HIV 感染治疗中替诺福韦突破二十周年大会上的约翰·C·马丁教授。
Viruses. 2021 Dec 2;13(12):2410. doi: 10.3390/v13122410.
7
Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq.对抗病毒研究与药物开发的毕生热情:埃里克·德·克勒克教授八十华诞
Biochem Pharmacol. 2021 Mar;185:114485. doi: 10.1016/j.bcp.2021.114485. Epub 2021 Feb 20.
8
Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday.核苷(酸)类抗病毒药物的发现:谨以此书献给埃里克·德·克勒克教授 80 华诞。
Molecules. 2021 Feb 9;26(4):923. doi: 10.3390/molecules26040923.
9
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs.抗击病毒感染的趋势和策略:FDA 批准的抗病毒药物综述。
Int J Biol Macromol. 2021 Mar 1;172:524-541. doi: 10.1016/j.ijbiomac.2021.01.076. Epub 2021 Jan 14.
10
Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.具有抗病毒活性的氨基磷酸酯和膦酰氨基甲酸酯(前药)。
Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618775243. doi: 10.1177/2040206618775243.